secwatch.observer — SEC 8-K summary
======================================

Issuer:     Certara, Inc. (CERT)
CIK:        0001827090
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001104659-21-100776
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Certara acquires Pinnacle 21 for $310M in cash and stock
--------------------------------------------------------

- Enterprise value $310M: $250M cash + $60M in newly issued Certara shares.
- Acquisition expected to be immediately accretive to revenue, revenue growth, and adjusted EBITDA margin.
- Pinnacle 21 provides FDA/PMDA-required clinical data standardization software; 22 of top 25 pharma companies are customers.
- Transaction unanimously approved; expected to close early Q4 2021 subject to regulatory approvals.
- Deal expands Certara's biosimulation platform into data fitness and regulatory software.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1827090/000110465921100776/0001104659-21-100776-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1827090/000110465921100776/tm2123444d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-100776

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer